Newronika S.P.A.

Newronika S.P.A. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Building Brain Computers Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normal daily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics and biotechnologies.

Company Details

Employees
27
Founded
-
Address
Via Torquato Tasso, 1, Cologno Monzese (Mi),lombardy 20093,italy
Email
in****@****ika.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Cologno Monzese (MI), Lombardy
Looking for a particular Newronika S.P.A. employee's phone or email?

Newronika S.p.a. Questions

News

Newronika Appoints Keith Carlton as Executive Chairman to Reinforce Strategic Leadership - Yahoo Finance

Newronika Appoints Keith Carlton as Executive Chairman to Reinforce Strategic Leadership Yahoo Finance

Newronika Receives CE Mark Approval for AlphaDBS, Advancing Adaptive Deep Brain Stimulation for Parkinson's Disease - PR Newswire

Newronika Receives CE Mark Approval for AlphaDBS, Advancing Adaptive Deep Brain Stimulation for Parkinson's Disease PR Newswire

DBS startup Newronika nets European approval for adaptive Parkinson's therapy - Fierce Biotech

DBS startup Newronika nets European approval for adaptive Parkinson's therapy Fierce Biotech

Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform - PR Newswire

Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform PR Newswire

Newronika closes €13.6 million funding round following US FDA approval for adaptive DBS trial - NeuroNews International

Newronika closes €13.6 million funding round following US FDA approval for adaptive DBS trial NeuroNews International

Newronika gets IDE from the FDA for adaptive DBS trial - BioWorld MedTech

Newronika gets IDE from the FDA for adaptive DBS trial BioWorld MedTech

Newronika wins CE mark for adaptive DBS for Parkinson’s - MassDevice

Newronika wins CE mark for adaptive DBS for Parkinson’s MassDevice

Italy’s Newronika raises €13.6M to build brain computers - Silicon Canals

Italy’s Newronika raises €13.6M to build brain computers Silicon Canals

Newronika wins FDA IDE for adaptive deep brain stim tech - MassDevice

Newronika wins FDA IDE for adaptive deep brain stim tech MassDevice

Newronika announces CE mark for AlphaDBS system - NeuroNews International

Newronika announces CE mark for AlphaDBS system NeuroNews International

Top Newronika S.P.A. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant